Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer biomarkers: a current perspective.

Chandan Kumar-Sinha1, Daniel R Rhodes, Jianjun Yu

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor 48109, USA. chakumar@umich.edu

Expert Review of Molecular Diagnostics
|July 25, 2003
PubMed
Summary

Genomic and proteomic studies identify novel prostate cancer biomarkers. Expression patterns of these markers show promise for diagnosis, progression, and survival prediction, pending further validation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>TERT</i> Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract.

European urology open science·2022
Same author

Biochemical characterization of the interaction between KRAS and Argonaute 2.

Biochemistry and biophysics reports·2022
Same author

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.

Nature·2021
Same author

Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.

Urology·2021
Same author

G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer.

Nature communications·2021
Same author

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

European urology oncology·2021

Area of Science:

  • Oncology
  • Genomics
  • Proteomics

Background:

  • Genomic and proteomic studies have identified numerous candidate biomarkers for prostate cancer.
  • These include known oncogenes, proliferation markers, and cytoskeletal proteins, alongside unexpected molecules involved in transcriptional repression and fatty acid metabolism.

Purpose of the Study:

  • To explore the potential of novel candidate biomarkers and multi-marker expression patterns for prostate cancer.
  • To assess their utility in diagnosis, disease progression monitoring, and survival prediction.

Main Methods:

  • Utilized genomic and proteomic approaches to identify candidate biomarkers.
  • Investigated expression patterns of multiple markers.

Main Results:

Related Experiment Videos

  • Identified a wide range of candidate biomarkers, including both expected and unexpected molecules.
  • Observed potential for expression patterns to serve as biomarkers for prostate cancer.

Conclusions:

  • Expression patterns represent a novel, clinically untested concept for understanding cancer complexity.
  • Clinical application requires rigorous validation of identified candidates using independent biochemical methods and large, diverse patient cohorts.